The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drug Safety and Pharmacovigilance Service Market Research Report 2024
Synopsis
The global Drug Safety and Pharmacovigilance Service market was valued at US$ 42 million in 2023 and is anticipated to reach US$ 56 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Safety and Pharmacovigilance Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Safety and Pharmacovigilance Service.
Report Scope
The Drug Safety and Pharmacovigilance Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Safety and Pharmacovigilance Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Safety and Pharmacovigilance Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BioPoint
Cmed
Drug Safety Solutions
Hilbrans
Orbis Clinical
Parexel
PharmaLex
ProPharma
SGS
SJ Pharma Consulting LLC
Vitrana
X7 Research
Segment by Type
Drug Safety Service
Drug Pharmacovigilance Service
Segment by Application
Experimental Stage
Clinical Stage
Postmarketing Stage
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Safety and Pharmacovigilance Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Drug Safety and Pharmacovigilance Service market was valued at US$ 42 million in 2023 and is anticipated to reach US$ 56 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Safety and Pharmacovigilance Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Safety and Pharmacovigilance Service.
Report Scope
The Drug Safety and Pharmacovigilance Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Safety and Pharmacovigilance Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Safety and Pharmacovigilance Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BioPoint
Cmed
Drug Safety Solutions
Hilbrans
Orbis Clinical
Parexel
PharmaLex
ProPharma
SGS
SJ Pharma Consulting LLC
Vitrana
X7 Research
Segment by Type
Drug Safety Service
Drug Pharmacovigilance Service
Segment by Application
Experimental Stage
Clinical Stage
Postmarketing Stage
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Safety and Pharmacovigilance Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Safety and Pharmacovigilance Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Drug Safety Service
1.2.3 Drug Pharmacovigilance Service
1.3 Market by Application
1.3.1 Global Drug Safety and Pharmacovigilance Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Experimental Stage
1.3.3 Clinical Stage
1.3.4 Postmarketing Stage
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Safety and Pharmacovigilance Service Market Perspective (2019-2030)
2.2 Drug Safety and Pharmacovigilance Service Growth Trends by Region
2.2.1 Global Drug Safety and Pharmacovigilance Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Safety and Pharmacovigilance Service Historic Market Size by Region (2019-2024)
2.2.3 Drug Safety and Pharmacovigilance Service Forecasted Market Size by Region (2025-2030)
2.3 Drug Safety and Pharmacovigilance Service Market Dynamics
2.3.1 Drug Safety and Pharmacovigilance Service Industry Trends
2.3.2 Drug Safety and Pharmacovigilance Service Market Drivers
2.3.3 Drug Safety and Pharmacovigilance Service Market Challenges
2.3.4 Drug Safety and Pharmacovigilance Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Safety and Pharmacovigilance Service Players by Revenue
3.1.1 Global Top Drug Safety and Pharmacovigilance Service Players by Revenue (2019-2024)
3.1.2 Global Drug Safety and Pharmacovigilance Service Revenue Market Share by Players (2019-2024)
3.2 Global Drug Safety and Pharmacovigilance Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Safety and Pharmacovigilance Service Revenue
3.4 Global Drug Safety and Pharmacovigilance Service Market Concentration Ratio
3.4.1 Global Drug Safety and Pharmacovigilance Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Safety and Pharmacovigilance Service Revenue in 2023
3.5 Drug Safety and Pharmacovigilance Service Key Players Head office and Area Served
3.6 Key Players Drug Safety and Pharmacovigilance Service Product Solution and Service
3.7 Date of Enter into Drug Safety and Pharmacovigilance Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Safety and Pharmacovigilance Service Breakdown Data by Type
4.1 Global Drug Safety and Pharmacovigilance Service Historic Market Size by Type (2019-2024)
4.2 Global Drug Safety and Pharmacovigilance Service Forecasted Market Size by Type (2025-2030)
5 Drug Safety and Pharmacovigilance Service Breakdown Data by Application
5.1 Global Drug Safety and Pharmacovigilance Service Historic Market Size by Application (2019-2024)
5.2 Global Drug Safety and Pharmacovigilance Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug Safety and Pharmacovigilance Service Market Size (2019-2030)
6.2 North America Drug Safety and Pharmacovigilance Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug Safety and Pharmacovigilance Service Market Size by Country (2019-2024)
6.4 North America Drug Safety and Pharmacovigilance Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Safety and Pharmacovigilance Service Market Size (2019-2030)
7.2 Europe Drug Safety and Pharmacovigilance Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug Safety and Pharmacovigilance Service Market Size by Country (2019-2024)
7.4 Europe Drug Safety and Pharmacovigilance Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Safety and Pharmacovigilance Service Market Size (2019-2030)
8.2 Asia-Pacific Drug Safety and Pharmacovigilance Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug Safety and Pharmacovigilance Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Drug Safety and Pharmacovigilance Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Safety and Pharmacovigilance Service Market Size (2019-2030)
9.2 Latin America Drug Safety and Pharmacovigilance Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug Safety and Pharmacovigilance Service Market Size by Country (2019-2024)
9.4 Latin America Drug Safety and Pharmacovigilance Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size (2019-2030)
10.2 Middle East & Africa Drug Safety and Pharmacovigilance Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BioPoint
11.1.1 BioPoint Company Detail
11.1.2 BioPoint Business Overview
11.1.3 BioPoint Drug Safety and Pharmacovigilance Service Introduction
11.1.4 BioPoint Revenue in Drug Safety and Pharmacovigilance Service Business (2019-2024)
11.1.5 BioPoint Recent Development
11.2 Cmed
11.2.1 Cmed Company Detail
11.2.2 Cmed Business Overview
11.2.3 Cmed Drug Safety and Pharmacovigilance Service Introduction
11.2.4 Cmed Revenue in Drug Safety and Pharmacovigilance Service Business (2019-2024)
11.2.5 Cmed Recent Development
11.3 Drug Safety Solutions
11.3.1 Drug Safety Solutions Company Detail
11.3.2 Drug Safety Solutions Business Overview
11.3.3 Drug Safety Solutions Drug Safety and Pharmacovigilance Service Introduction
11.3.4 Drug Safety Solutions Revenue in Drug Safety and Pharmacovigilance Service Business (2019-2024)
11.3.5 Drug Safety Solutions Recent Development
11.4 Hilbrans
11.4.1 Hilbrans Company Detail
11.4.2 Hilbrans Business Overview
11.4.3 Hilbrans Drug Safety and Pharmacovigilance Service Introduction
11.4.4 Hilbrans Revenue in Drug Safety and Pharmacovigilance Service Business (2019-2024)
11.4.5 Hilbrans Recent Development
11.5 Orbis Clinical
11.5.1 Orbis Clinical Company Detail
11.5.2 Orbis Clinical Business Overview
11.5.3 Orbis Clinical Drug Safety and Pharmacovigilance Service Introduction
11.5.4 Orbis Clinical Revenue in Drug Safety and Pharmacovigilance Service Business (2019-2024)
11.5.5 Orbis Clinical Recent Development
11.6 Parexel
11.6.1 Parexel Company Detail
11.6.2 Parexel Business Overview
11.6.3 Parexel Drug Safety and Pharmacovigilance Service Introduction
11.6.4 Parexel Revenue in Drug Safety and Pharmacovigilance Service Business (2019-2024)
11.6.5 Parexel Recent Development
11.7 PharmaLex
11.7.1 PharmaLex Company Detail
11.7.2 PharmaLex Business Overview
11.7.3 PharmaLex Drug Safety and Pharmacovigilance Service Introduction
11.7.4 PharmaLex Revenue in Drug Safety and Pharmacovigilance Service Business (2019-2024)
11.7.5 PharmaLex Recent Development
11.8 ProPharma
11.8.1 ProPharma Company Detail
11.8.2 ProPharma Business Overview
11.8.3 ProPharma Drug Safety and Pharmacovigilance Service Introduction
11.8.4 ProPharma Revenue in Drug Safety and Pharmacovigilance Service Business (2019-2024)
11.8.5 ProPharma Recent Development
11.9 SGS
11.9.1 SGS Company Detail
11.9.2 SGS Business Overview
11.9.3 SGS Drug Safety and Pharmacovigilance Service Introduction
11.9.4 SGS Revenue in Drug Safety and Pharmacovigilance Service Business (2019-2024)
11.9.5 SGS Recent Development
11.10 SJ Pharma Consulting LLC
11.10.1 SJ Pharma Consulting LLC Company Detail
11.10.2 SJ Pharma Consulting LLC Business Overview
11.10.3 SJ Pharma Consulting LLC Drug Safety and Pharmacovigilance Service Introduction
11.10.4 SJ Pharma Consulting LLC Revenue in Drug Safety and Pharmacovigilance Service Business (2019-2024)
11.10.5 SJ Pharma Consulting LLC Recent Development
11.11 Vitrana
11.11.1 Vitrana Company Detail
11.11.2 Vitrana Business Overview
11.11.3 Vitrana Drug Safety and Pharmacovigilance Service Introduction
11.11.4 Vitrana Revenue in Drug Safety and Pharmacovigilance Service Business (2019-2024)
11.11.5 Vitrana Recent Development
11.12 X7 Research
11.12.1 X7 Research Company Detail
11.12.2 X7 Research Business Overview
11.12.3 X7 Research Drug Safety and Pharmacovigilance Service Introduction
11.12.4 X7 Research Revenue in Drug Safety and Pharmacovigilance Service Business (2019-2024)
11.12.5 X7 Research Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Drug Safety and Pharmacovigilance Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Drug Safety Service
Table 3. Key Players of Drug Pharmacovigilance Service
Table 4. Global Drug Safety and Pharmacovigilance Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Drug Safety and Pharmacovigilance Service Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Drug Safety and Pharmacovigilance Service Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Drug Safety and Pharmacovigilance Service Market Share by Region (2019-2024)
Table 8. Global Drug Safety and Pharmacovigilance Service Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Drug Safety and Pharmacovigilance Service Market Share by Region (2025-2030)
Table 10. Drug Safety and Pharmacovigilance Service Market Trends
Table 11. Drug Safety and Pharmacovigilance Service Market Drivers
Table 12. Drug Safety and Pharmacovigilance Service Market Challenges
Table 13. Drug Safety and Pharmacovigilance Service Market Restraints
Table 14. Global Drug Safety and Pharmacovigilance Service Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Drug Safety and Pharmacovigilance Service Market Share by Players (2019-2024)
Table 16. Global Top Drug Safety and Pharmacovigilance Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Safety and Pharmacovigilance Service as of 2023)
Table 17. Ranking of Global Top Drug Safety and Pharmacovigilance Service Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Drug Safety and Pharmacovigilance Service Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Drug Safety and Pharmacovigilance Service Product Solution and Service
Table 21. Date of Enter into Drug Safety and Pharmacovigilance Service Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug Safety and Pharmacovigilance Service Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Drug Safety and Pharmacovigilance Service Revenue Market Share by Type (2019-2024)
Table 25. Global Drug Safety and Pharmacovigilance Service Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Drug Safety and Pharmacovigilance Service Revenue Market Share by Type (2025-2030)
Table 27. Global Drug Safety and Pharmacovigilance Service Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Drug Safety and Pharmacovigilance Service Revenue Market Share by Application (2019-2024)
Table 29. Global Drug Safety and Pharmacovigilance Service Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Drug Safety and Pharmacovigilance Service Revenue Market Share by Application (2025-2030)
Table 31. North America Drug Safety and Pharmacovigilance Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Drug Safety and Pharmacovigilance Service Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Drug Safety and Pharmacovigilance Service Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Drug Safety and Pharmacovigilance Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Drug Safety and Pharmacovigilance Service Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Drug Safety and Pharmacovigilance Service Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Drug Safety and Pharmacovigilance Service Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Drug Safety and Pharmacovigilance Service Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Drug Safety and Pharmacovigilance Service Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Drug Safety and Pharmacovigilance Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Drug Safety and Pharmacovigilance Service Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Drug Safety and Pharmacovigilance Service Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size by Country (2025-2030) & (US$ Million)
Table 46. BioPoint Company Detail
Table 47. BioPoint Business Overview
Table 48. BioPoint Drug Safety and Pharmacovigilance Service Product
Table 49. BioPoint Revenue in Drug Safety and Pharmacovigilance Service Business (2019-2024) & (US$ Million)
Table 50. BioPoint Recent Development
Table 51. Cmed Company Detail
Table 52. Cmed Business Overview
Table 53. Cmed Drug Safety and Pharmacovigilance Service Product
Table 54. Cmed Revenue in Drug Safety and Pharmacovigilance Service Business (2019-2024) & (US$ Million)
Table 55. Cmed Recent Development
Table 56. Drug Safety Solutions Company Detail
Table 57. Drug Safety Solutions Business Overview
Table 58. Drug Safety Solutions Drug Safety and Pharmacovigilance Service Product
Table 59. Drug Safety Solutions Revenue in Drug Safety and Pharmacovigilance Service Business (2019-2024) & (US$ Million)
Table 60. Drug Safety Solutions Recent Development
Table 61. Hilbrans Company Detail
Table 62. Hilbrans Business Overview
Table 63. Hilbrans Drug Safety and Pharmacovigilance Service Product
Table 64. Hilbrans Revenue in Drug Safety and Pharmacovigilance Service Business (2019-2024) & (US$ Million)
Table 65. Hilbrans Recent Development
Table 66. Orbis Clinical Company Detail
Table 67. Orbis Clinical Business Overview
Table 68. Orbis Clinical Drug Safety and Pharmacovigilance Service Product
Table 69. Orbis Clinical Revenue in Drug Safety and Pharmacovigilance Service Business (2019-2024) & (US$ Million)
Table 70. Orbis Clinical Recent Development
Table 71. Parexel Company Detail
Table 72. Parexel Business Overview
Table 73. Parexel Drug Safety and Pharmacovigilance Service Product
Table 74. Parexel Revenue in Drug Safety and Pharmacovigilance Service Business (2019-2024) & (US$ Million)
Table 75. Parexel Recent Development
Table 76. PharmaLex Company Detail
Table 77. PharmaLex Business Overview
Table 78. PharmaLex Drug Safety and Pharmacovigilance Service Product
Table 79. PharmaLex Revenue in Drug Safety and Pharmacovigilance Service Business (2019-2024) & (US$ Million)
Table 80. PharmaLex Recent Development
Table 81. ProPharma Company Detail
Table 82. ProPharma Business Overview
Table 83. ProPharma Drug Safety and Pharmacovigilance Service Product
Table 84. ProPharma Revenue in Drug Safety and Pharmacovigilance Service Business (2019-2024) & (US$ Million)
Table 85. ProPharma Recent Development
Table 86. SGS Company Detail
Table 87. SGS Business Overview
Table 88. SGS Drug Safety and Pharmacovigilance Service Product
Table 89. SGS Revenue in Drug Safety and Pharmacovigilance Service Business (2019-2024) & (US$ Million)
Table 90. SGS Recent Development
Table 91. SJ Pharma Consulting LLC Company Detail
Table 92. SJ Pharma Consulting LLC Business Overview
Table 93. SJ Pharma Consulting LLC Drug Safety and Pharmacovigilance Service Product
Table 94. SJ Pharma Consulting LLC Revenue in Drug Safety and Pharmacovigilance Service Business (2019-2024) & (US$ Million)
Table 95. SJ Pharma Consulting LLC Recent Development
Table 96. Vitrana Company Detail
Table 97. Vitrana Business Overview
Table 98. Vitrana Drug Safety and Pharmacovigilance Service Product
Table 99. Vitrana Revenue in Drug Safety and Pharmacovigilance Service Business (2019-2024) & (US$ Million)
Table 100. Vitrana Recent Development
Table 101. X7 Research Company Detail
Table 102. X7 Research Business Overview
Table 103. X7 Research Drug Safety and Pharmacovigilance Service Product
Table 104. X7 Research Revenue in Drug Safety and Pharmacovigilance Service Business (2019-2024) & (US$ Million)
Table 105. X7 Research Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug Safety and Pharmacovigilance Service Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Drug Safety and Pharmacovigilance Service Market Share by Type: 2023 VS 2030
Figure 3. Drug Safety Service Features
Figure 4. Drug Pharmacovigilance Service Features
Figure 5. Global Drug Safety and Pharmacovigilance Service Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Drug Safety and Pharmacovigilance Service Market Share by Application: 2023 VS 2030
Figure 7. Experimental Stage Case Studies
Figure 8. Clinical Stage Case Studies
Figure 9. Postmarketing Stage Case Studies
Figure 10. Other Case Studies
Figure 11. Drug Safety and Pharmacovigilance Service Report Years Considered
Figure 12. Global Drug Safety and Pharmacovigilance Service Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Drug Safety and Pharmacovigilance Service Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Drug Safety and Pharmacovigilance Service Market Share by Region: 2023 VS 2030
Figure 15. Global Drug Safety and Pharmacovigilance Service Market Share by Players in 2023
Figure 16. Global Top Drug Safety and Pharmacovigilance Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Safety and Pharmacovigilance Service as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Drug Safety and Pharmacovigilance Service Revenue in 2023
Figure 18. North America Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Drug Safety and Pharmacovigilance Service Market Share by Country (2019-2030)
Figure 20. United States Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Drug Safety and Pharmacovigilance Service Market Share by Country (2019-2030)
Figure 24. Germany Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Drug Safety and Pharmacovigilance Service Market Share by Region (2019-2030)
Figure 32. China Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Drug Safety and Pharmacovigilance Service Market Share by Country (2019-2030)
Figure 40. Mexico Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Share by Country (2019-2030)
Figure 44. Turkey Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. BioPoint Revenue Growth Rate in Drug Safety and Pharmacovigilance Service Business (2019-2024)
Figure 47. Cmed Revenue Growth Rate in Drug Safety and Pharmacovigilance Service Business (2019-2024)
Figure 48. Drug Safety Solutions Revenue Growth Rate in Drug Safety and Pharmacovigilance Service Business (2019-2024)
Figure 49. Hilbrans Revenue Growth Rate in Drug Safety and Pharmacovigilance Service Business (2019-2024)
Figure 50. Orbis Clinical Revenue Growth Rate in Drug Safety and Pharmacovigilance Service Business (2019-2024)
Figure 51. Parexel Revenue Growth Rate in Drug Safety and Pharmacovigilance Service Business (2019-2024)
Figure 52. PharmaLex Revenue Growth Rate in Drug Safety and Pharmacovigilance Service Business (2019-2024)
Figure 53. ProPharma Revenue Growth Rate in Drug Safety and Pharmacovigilance Service Business (2019-2024)
Figure 54. SGS Revenue Growth Rate in Drug Safety and Pharmacovigilance Service Business (2019-2024)
Figure 55. SJ Pharma Consulting LLC Revenue Growth Rate in Drug Safety and Pharmacovigilance Service Business (2019-2024)
Figure 56. Vitrana Revenue Growth Rate in Drug Safety and Pharmacovigilance Service Business (2019-2024)
Figure 57. X7 Research Revenue Growth Rate in Drug Safety and Pharmacovigilance Service Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
